IP Library Granted Patent US 8,246,681
Granted Patent B2
US 8,246,681 · App. 11/978,271 · Granted Aug 21, 2012

Methods for treating a fractured and/or diseased and/or weakened bone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,246,681
App. No.
11/978,271
Granted
Aug 21, 2012
Kind
B2
Abstract

Introduction of a bone filler material into at least a portion of the cancellous bone volume pressurizes the bone filler material and compresses the cancellous bone volume within the bone structure.

Claims (31)

1. A method comprising

establishing a percutaneous path into a vertebral body having cortical bone enclosing a cancellous bone volume,

forming a cavity in the cancellous bone volume,

compressing at least a portion of the cancellous bone volume by injecting a pressurized flowable bone filler material directly into the cavity,

pushing the flowable bone filler material outward against the walls of the cavity to increase the size of the cavity by injecting additional flowable bone filler material into the cavity; and

moving a fractured cortical bone of the vertebral body to a pre-fractured position by injecting additional flowable bone filler material into the cavity.

2. A method according to claim 1 , wherein the flowable bone filler material comprises a bone cement.

3. A method according to claim 1 , wherein the bone filler material comprises a bone cement.

4. A method of claim 1 , wherein the flowable bone filler material comprises a bone cement.

5. A method comprising

establishing a percutaneous path into a bone structure having cortical bone enclosing a cancellous bone volume,

introducing a flowable bone filler material directly into at least a portion of the cancellous bone volume,

pressurizing the flowable bone filler material within the bone structure by continuing the introduction of the flowable bone filler material into the cancellous bone volume,

compressing the cancellous bone volume within the bone structure by the pressurizing of the flowable bone filler material; and

moving a fractured cortical bone of the vertebral body to a pre-fractured position by injecting additional flowable bone filler material into the cavity.

6. A method according to claim 5 wherein the pressurizing of the flowable bone filler material within the bone structure moves fractured cortical bone.

7. A method according to claim 5 wherein the bone structure comprises a vertebral body.

8. A method according to claim 5 wherein the flowable bone filler material comprises a bone cement.

9. A method according to claim 5 , wherein the flowable bone filler material comprises at least one of a bone filler, a bone cement, a synthetic bone substitute, a bone biomaterial, a hydroxyapatite material, a bone mineral material, a thixotropic material, a curable biomaterial, allograft tissue, and autograft tissue.

10. A method comprising

creating a cavity a vertebral body,

introducing a first amount of a flowable bone filler material directly into the cavity,

introducing a second amount of pressurized flowable bone filler material into the cavity such that the flowable bone filler material pushes outward against a wall of the cavity, thereby compressing a cancellous bone in the vertebral body and increasing the size of the cavity; and

moving the cortical bone until the fractured cortical bone regains a pre-fractured position.

11. A method according to claim 9 wherein introducing the second amount of the flowable bone filler material moves fractured cortical bone of the vertebral body.

12. A method comprising

compressing at least a portion of a cancellous bone volume within a vertebral body by injecting a flowable bone filler material directly into the cancellous bone volume,

moving fractured cortical bone of the vertebral body by injecting pressurized flowable bone filler material into the vertebral body,

comprising moving fractured cortical bone to a pre-fractured position.

13. A method according to claim 12 wherein the flowable bone filler comprises a bone cement.

14. A method according to claim 12 , wherein the flowable bone filler material comprises at least one of a bone filler, a bone cement, a synthetic bone substitute, a bone biomaterial, a hydroxyapatite material, a bone mineral material, a thixotropic material, a curable biomaterial, allograft tissue, and autograft tissue.

Assignments (4)
SECURITY INTEREST Recorded Jan 11, 2017
From: MOTHEYE TECHNOLOGIES, LLC; SYNCHRONICITY IP LLC; TRAVERSE TECHNOLOGIES CORP.; 3D NANOCOLOR CORP.; BISMARCK IP INC.; MAGNUS IP GMBH; MUNITECH IP S.À.R.L.; VERMILION PARTICIPATIONS; MARATHON VENTURES S.À.R.L; NYANZA PROPERTIES; MARATHON IP GMBH; ORTHOPHOENIX, LLC; MEDTECH DEVELOPMENT DEUTSCHLAND GMBH; SYNCHRONICITY IP GMBH; TLI COMMUNICATIONS GMBH
To: DBD CREDIT FUNDING LLC, AS COLLATERAL AGENT
Reel/Frame 041333/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2015
From: OSORIO, REYNALDO A.; FOLLMER, MARIALULU; LAYNE, RICHARD W.; BOUCHER, RYAN P.; TALMADGE, KAREN D.; BASISTA, JOSEPH J.
To: KYPHON INC.
Reel/Frame 036073/0541 →
CHANGE OF NAME Recorded Jul 13, 2015
From: KYPHON INC.
To: MEDTRONIC SPINE LLC
Reel/Frame 036101/0691 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2015
From: KYPHON SARL
To: ORTHOPHOENIX, LLC
Reel/Frame 035307/0018 →